Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand

Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand

© 2020 The Authors A new generation of recombinant acellular pertussis vaccine containing genetically inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aPgen; Pertagen®) and in combination with tetanus and reduced-dose diphtheria (TdaPgen; Boostagen®) for active imm...

Full description

Saved in:
Bibliographic Details
Main Authors: Librada Fortuna, Surasith Chaithongwongwatthana, Ngamphol Soonthornworasiri, Jane Spiegel, Wassana Wijagkanalan, Souad Mansouri, Anita H.J. van den Biggelaar, Hong Thai Pham
Other Authors: Chulalongkorn University
Format: Article
Published: 2020
Subjects:
Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/59894
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/59894

Similar Items